Squeeze the Patent: How Drug Companies Use Reformulation and New Indications to Outlast Generic Competition
The blockbuster drug model has a built-in expiration date. From the moment a pharmaceutical company files its first patent, the […]
GPT-Rosalind and Generic Drugs: What OpenAI’s Life Sciences Model Actually Changes
Part One: What GPT-Rosalind Is and What OpenAI Is Selling The Model Architecture GPT-Rosalind is the first in what OpenAI
GPT-Rosalind and Generic Drugs: What OpenAI’s Life Sciences Model Actually Changes Read Post »
Beat the Patent Cliff: How to Trigger Payer Strategy Campaigns Before Drug Patent LOE
A systematic, intelligence-led playbook for commercial and market access vendors targeting pre-LOE mandates with health plans, PBMs, IDNs, and brand
Beat the Patent Cliff: How to Trigger Payer Strategy Campaigns Before Drug Patent LOE Read Post »
OpenAI’s GPT-Rosalind = Smashed Drug Patent Cliffs and 70% Faster ANDAs
The launch of OpenAI GPT-Rosalind on April 17, 2026, marks the end of the traditional patent cliff as a predictable
OpenAI’s GPT-Rosalind = Smashed Drug Patent Cliffs and 70% Faster ANDAs Read Post »
Predict the Attack: How to Forecast Paragraph IV Drug Patent Challenge Filings and Neutralize Skinny Label Threats
The Generic Entry Problem Nobody States Plainly Every branded pharmaceutical product has a clock on it. The moment the FDA
Know Exactly How Long Your Drug Patent Lasts in the GCC
Why the GCC Derails Pharma IP Teams That Know the U.S. System Cold There is a particular category of expensive
Know Exactly How Long Your Drug Patent Lasts in the GCC Read Post »
Read the Patent Trail: 4 Signals Your Competitor Is Extending a Drug’s Life
The Notice That Never Gets Sent Pharmaceutical companies do not issue press releases announcing lifecycle extension campaigns. They do not
Read the Patent Trail: 4 Signals Your Competitor Is Extending a Drug’s Life Read Post »
Time the Pitch: How Biopharma Packaging BizDev Teams Win by Aligning Child-Resistant Drug Packaging Campaigns with Drug Patent LOE Timeline
Executive Summary Most biopharma packaging sales reps knock on the wrong doors at the wrong time. They call on brand-side
GPT-Rosalind: What OpenAI’s Life Sciences Model Actually Does to Drug Development
On April 16, 2026, OpenAI did something it had never done before: it shipped a model designed not to chat,
GPT-Rosalind: What OpenAI’s Life Sciences Model Actually Does to Drug Development Read Post »
